GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Entia Biosciences ERGO · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Entia Biosciences annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In USD.

FY2016FY2015FY2014
Revenue$265,466$346,910$656,342
Operating income−$1.2m−$1.9m−$1.8m
Net income−$1.5m−$2.4m−$2.6m
Free cash flow−$722,215−$557,851−$725,748
Total assets$439,141$448,606$870,708
Shareholders' equity−$2.0m−$791,188−$116,536

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.